Cutan T-cell lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of malignant T-cells in the skin and lymph nodes, particularly affecting unspecified nodes of the head, face, and neck. This condition is clinically significant due to its potential for aggressive behavior and the need for accurate diagnosis and treatment. The ICD-10 Code C84.A1 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this malignancy.
ICD-10 Code C84.A1 represents Cutan T-cell lymphoma affecting unspecified lymph nodes of the head, face, and neck. This code is used when a patient presents with symptoms indicative of this malignancy, allowing for appropriate clinical documentation and billing. It is essential for capturing the complexity of the disease and ensuring that healthcare providers can deliver targeted treatment and follow-up care.
Cutan T-cell lymphoma is a hematological malignancy that arises from T-lymphocytes and primarily affects the skin and lymphatic system. The exact etiology is often unknown, but it may be associated with environmental factors, genetic predispositions, or immune system dysfunction. Early detection and intervention are crucial due to the potential for disease progression and complications.
In clinical workflows, ICD-10 Code C84.A1 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and reimbursement processes.
ICD-10 Code C84.A1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutan T-cell lymphoma. This linkage is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Cutan T-cell lymphoma requires a multidisciplinary approach, often necessitating hospitalization for advanced therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.A1 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count with differential and platelet count. |
| 88305 | Pathology examination of tissue, including biopsy. |
Common Questions About Using ICD-10 Code C84.A1 for Cutan T-cell lymphoma, unsp nodes of head, face, and neck
What are the common symptoms of Cutan T-cell lymphoma?
Common symptoms include skin lesions that may appear as red, scaly patches or plaques, itching, and lymphadenopathy in the head and neck regions. Systemic symptoms such as fever and weight loss may also occur.
How is Cutan T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of clinical examination, imaging studies, and biopsy of affected skin or lymph nodes to confirm the presence of atypical T-cells.
What treatment options are available for Cutan T-cell lymphoma?
Treatment options may include topical therapies, systemic chemotherapy, and radiation therapy, depending on the stage and severity of the disease.
Is Cutan T-cell lymphoma contagious?
No, Cutan T-cell lymphoma is not contagious. It is a malignancy arising from T-cells and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes